Transforming Pharma for a Digital Future

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

My journey in healthcare began with an unwavering passion for science and service—a passion that took root early in my career.

I had the honor of serving as COO at Johnson & Johnson, where every decision was influenced by our Credo. That report is not a collection of words; it's the pulse of J&J, reminding us of every day that our highest responsibility is to patients, healthcare professionals, and the communities we serve.

While at J&J, I spearheaded efforts that enhanced operational excellence and embedded patient-focused thinking into all levels of our organization. I learned that true leadership in healthcare means balancing commercial success with ethical responsibility and a genuine commitment to improving lives.

Later, as CEO of Cadila, I carried forward these lessons—focusing on innovation, efficiency, and a deep-seated belief in “health for humanity.” Whether spearheading initiatives in biosimilars or advancing personalized medicine, I’ve always viewed every project through the lens of our shared responsibility to deliver better patient outcomes.

My work as an investor further reinforces this commitment. I seek out opportunities that promise growth and…